Breast Cancer Tissue Array of 96 Tissue Samples
      Home >> Welcome to Pantomics                                                                          Price List Download

Dedicated facility

 Catalog# BRC961C_F - Human breast cancer tissue array

   
Lot# Cores Size Cut Format QA/QC Price
1Slide
Price
Pack5
BRC96102 96 1.5mm 4um 8X12 H&E, IHC anti-Vimentin/Cytokeratin $150 $600
Order: sales@pantomics.com or call  1-415-863-2380, Form: Word or PDF; PDF data
 
   
Recommended applications: For Research use only. RNA or protein breast cancer/non-tumor tissue profiling using IHC or ISH; Antibody characterization.

Description:
Breast cancer tissue array, 96 cores including 36 cases (purple/blue) of breast cancers and 12 cases of normal, reactive and  benign tumor tissues of the breast (pink) in duplicates. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention.
   
   

Array
position

Age

Sex

Histology

Grade

Stage (TNM)

AR

ER

PR

HER2

A1,B1

50

F

Normal

 

 

+~++, 30%

+~++, 15%

-

-

A2,B2

43

F

Normal

 

 

+~++, 20%

+, 5%

++, 15%

++

A3,B3

50

F

Normal

 

 

+~++, 20%

+~++, 15%

+, 5%

-

A4,B4

30

F

Periductual mastitis

 

 

+~++, 20%

+~++, 5%

++, 5%

-

A5,B5

52

F

Hyperplasia

 

 

-

+~++, 10%

++, 10%

-

A6,B6

38

F

Hyperplasia

 

 

-

+~++, 5%

++, 5%

-

A7,B7

41

F

Hyperplasia

 

 

+, 20%

+, 15%

++, 20%

-

A8,B8

40

F

Fibrocystic changes

 

 

+~++, 20%

+~++, 15%

+~++, 20%

+

A9,B9

41

F

Fibrocystic changes

 

 

+, 20%

+~++, 15%

++~+++, 30%

+

A10,B10

39

F

Fibroadenoma

 

 

+, 5%

+~++, 5%

+~++, 10%

+

A11,B11

16

F

Fibroadenoma

 

 

+, 50%

++~+++, 80%

++~+++, 80%

+-

A12,B12

34

F

Fibroadenoma

 

 

+~++, 30%

++~+++, 20%

++~+++, 20%

+

C1,D1

38

F

Phyllodes sarcoma

 

TisN0M0

+~++, 10%

+~++, 10%

++~+++, 50%

+~++

C2,D2

52

F

Intraductal carcinoma

I

TisN0M0

+-

+++, 80%

-

++~+++

C3,D3

33

F

Intraductal carcinoma

I

TisN0M0

+-

++, 20%

++~+++, 50%

++~+++

C4,D4

37

F

Invasive ductal carcinoma (partially intraductal carcinoma)

I~II

T3N1M1

+~++, 20%

++~+++, 60%

++~+++, 50%

+

C5,D5

53

F

Intraductal carcinoma

I

TisN0M0

+, 15%

-

-

+++

C6,D6

61

M

Ductal papillary adenocarcinoma

I~II

T2N0M0

+, 15%

+~++, 20%

+~++, 10%

+

C7,D7

41

F

Invasive ductal carcinoma

II

T2N0M0

++, 5%

++, 5%

++~+++, 10%

+

C8,D8

55

F

Invasive ductal carcinoma

III

T3N2M0

+~++, 5%

+, 50%

+~++, 5%

+

C9,D9

44

F

Invasive ductal carcinoma

II~III

T3N0M0

-

-

-

-

C10,D10

72

F

Invasive ductal carcinoma

II

T2N0M0

++, 20%

-

-

++~+++

C11,D11

41

F

Invasive ductal carcinoma

II

T3N2M0

-

+, 5%

-

+++

C12,D12

18

F

Invasive ductal carcinoma

II~III

T2N0M0

+-

+~++, 5%

+~++, 5%

+

E1,F1

31

F

Invasive ductal carcinoma

II~III

T2N0M0

+-

-

-

+++

E2,F2

54

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

+++

E3,F3

75

F

Invasive ductal carcinoma

III

T3N0M0

++, 30%

+, 10%

+~++, 10%

-

E4,F4

30

F

Invasive ductal carcinoma

I~II

T3N0M0

-

-

+~++, 5%

-

E5,F5

43

F

Invasive ductal carcinoma

III

T3N0M0

-

-

-

-

E6,F6

37

F

Invasive ductal carcinoma

III

T2N0M0

-

-

+~++, 5%

+++

E7,F7

42

F

Invasive ductal carcinoma

II~III

T4N2MX

-

+, 50%

++~+++, 60%

+

E8,F8

30

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

-

E9,F9

39

F

Invasive ductal carcinoma

I~II

T3N0M0

-

++~+++, 50%

+~++, 50%

+-

E10,F10

46

F

Invasive ductal carcinoma

III

T2N0M0

+-

+, 5%

-

+

E11,F11

40

F

Invasive ductal carcinoma

II

T3N1M0

-

+, 10%

+~++, 10%

-

E12,F12

58

F

Invasive ductal carcinoma

II

T3N0M0

-

-

-

++~+++

G1,H1

35

F

Invasive ductal carcinoma

III

T2N0M0

++~+++, 60%

++~+++, 30%

+~++, 10%

+++

G2,H2

53

F

Invasive ductal carcinoma

II~III

T2N0M0

++~+++, 10%

+~++, 10%

-

+++

G3,H3

50

F

Invasive ductal carcinoma

II~III

T4N3M1

-

+, 5%

+, 5%

+

G4,H4

48

F

Invasive ductal carcinoma

II~III

T2N0M0

+, 5%

++~+++, 30%

++~+++, 50%

+-

G5,H5

51

F

Invasive ductal carcinoma

II

T3N1M0

+-

++, 50%

+~++, 15%

-

G6,H6

43

F

Invasive ductal carcinoma

II~III

T4N2MX

-

-

-

+++

G7,H7

43

F

Invasive ductal carcinoma

II~III

T3N1M0

+-

-

-

+~++

G8,H8

40

F

Invasive ductal carcinoma

III

T3N0M0

-

-

-

+++

G9,H9

47

F

Invasive ductal carcinoma

III

T3N1M0

-

-

-

++~+++

G10,H10

49

F

Invasive ductal carcinoma

II~III

T3N1M0

+~++, 5%

++~+++, 20%

++~+++, 60%

+

G11,H11

58

F

Invasive mucinous adenocarcinoma

 

T3N2M0

-

-

-

+~++

G12,H12

40

F

Invasive lobular carcinoma

III

T2N0M0

+-

++~+++, 50%

+~++, 15%

-

 

Notes: Bake at 60C for 30 minutes before use. “-“ – no staining; “+-“ – borderline staining; “+” – weak staining; “++” – moderate staining; “+++” – strong staining; “%” – percentage of positive cells.

 

-------------------------------------------------------------------------------------------------
All Products | Ordering Information | Privacy Policy
Copyright © 2004-2005, Pantomics, Inc.
457 Mariposa Street, San Francisco, CA 94107, USA. Tel: 415-863-2380